nature.com search

Loading Filters

Showing 1–17 of 17 results

Loading Filters

Amendments and Corrections | 3 May 2017
Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence
- A Tefferi
- , H K Al-Ali
- , G Barosi
- , T Devos
- , H Gisslinger
- , Q Jiang
- , J-J Kiladjian
- , R Mesa
- , F Passamonti
- , M F McMullin
- , V Ribrag
- , G Schiller
- , A M Vannucchi
- , D Zhou
- , D Reiser
- , J Zhong
- & R P Gale
Leukemia 31 , 1252–1252

Rights & permissionsfor article Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence . Opens in a new window.
Research | 24 October 2016 | Open
A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence
- A Tefferi
- , H K Al-Ali
- , G Barosi
- , T Devos
- , H Gisslinger
- , Q Jiang
- , J-J Kiladjian
- , R Mesa
- , F Passamonti
- , V Ribrag
- , G Schiller
- , A M Vannucchi
- , D Zhou
- , D Reiser
- , J Zhong
- & R P Gale
Leukemia 31 , 896–902

Rights & permissionsfor article A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence . Opens in a new window.
Research | 19 September 2016
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
- E Van Den Neste
- , N Schmitz
- , N Mounier
- , D Gill
- , D Linch
- , M Trneny
- , R Bouadballah
- , J Radford
- , M Bargetzi
- , V Ribrag
- , U Dührsen
- , D Ma
- , J Briere
- , C Thieblemont
- , E Bachy
- , C H Moskowitz
- , B Glass
- & C Gisselbrecht
Bone Marrow Transplantation 52 , 216–221

Rights & permissionsfor article Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study . Opens in a new window.
24 November 2015
Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials
- E Hoster
- , C H Geisler
- , J Doorduijn
- , B van der Holt
- , J Walewski
- , J Bloehdorn
- , V Ribrag
- , G Salles
- , M Hallek
- , C Pott
- , M Szymczyk
- , A Kolstad
- , A Laurell
- , R Räty
- , M Jerkeman
- , M van't Veer
- , J C Kluin-Nelemans
- , W Klapper
- , M Unterhalt
- , M Dreyling
- & O Hermine
Leukemia 30 , 1428–1430

Rights & permissionsfor article Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials . Opens in a new window.
12 September 2014
Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
- X Cabagnols
- , J P Defour
- , V Ugo
- , J C Ianotto
- , P Mossuz
- , J Mondet
- , F Girodon
- , J H Alexandre
- , O Mansier
- , J F Viallard
- , E Lippert
- , A Murati
- , M J Mozziconacci
- , P Saussoy
- , M C Vekemans
- , L Knoops
- , F Pasquier
- , V Ribrag
- , E Solary
- , I Plo
- , S N Constantinescu
- , N Casadevall
- , W Vainchenker
- , C Marzac
- & O Bluteau
Leukemia 29 , 249–252

Rights & permissionsfor article Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution . Opens in a new window.
Research | 9 March 2000
Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice
- JM Vantelon
- , S Koscielny
- , P Brault
- , JH Bourhis
- , V Ribrag
- , J Pico
- , P Fenaux
- & JN Munck
Bone Marrow Transplantation 25 , 495–499

Rights & permissionsfor article Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice . Opens in a new window.
Research | 20 April 2001
Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy
- JM Vantelon
- , JN Munck
- , JH Bourhis
- , JL Pico
- , C Fadel
- , A Ulusakarya
- , P Carde
- , P Fenaux
- & V Ribrag
Bone Marrow Transplantation 27 , 531–536

Rights & permissionsfor article Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy . Opens in a new window.
Research | 27 February 2006
Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol
- J-P Lotz
- , P Pautier
- , F Selle
- , P Viens
- , M Fabbro
- , F Lokiec
- , F Viret
- , J Gligorov
- , B Gosse
- , S Provent
- , V Ribrag
- , J-M Micléa
- , C Dosquet
- , A Goetschel
- , C Cailliot
- , G Lefèvre
- , J Genève
- & C Lhommé
Bone Marrow Transplantation 37 , 669–675

Rights & permissionsfor article Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol . Opens in a new window.
Research | 14 May 1998
VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease
- V Ribrag
- , F Nasr
- , JH Bouhris
- , J Bosq
- , P Brault
- , T Girinsky
- , JM Cosset
- , JN Munck
- , C Corti
- , D Decaudin
- , JL Pico
- , M Hayat
- & P Carde
Bone Marrow Transplantation 21 , 969–974

Rights & permissionsfor article VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease . Opens in a new window.
Research | 2 March 2006
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)
- E Jabbour
- , S Koscielny
- , C Sebban
- , N Peslin
- , C Patte
- , T Gargi
- , P Biron
- , C Fermé
- , J H Bourhis
- , J M Vantelon
- , P Arnaud
- & V Ribrag
Leukemia 20 , 814–819

Rights & permissionsfor article High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL) . Opens in a new window.
11 September 2003
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma
- R M'kacher
- , A Bennaceur
- , F Farace
- , A Laugé
- , L F Plassa
- , E Wittmer
- , J Dossou
- , D Violot
- , E Deutsch
- , J Bourhis
- , D Stoppa-Lyonnet
- , V Ribrag
- , P Carde
- , C Parmentier
- , A Bernheim
- & A G Turhan
Oncogene 22 , 7905–7912

Rights & permissionsfor article Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma . Opens in a new window.
15 May 2003
Prognostic value of GST-π expression in diffuse large B-cell lymphomas
- V Ribrag
- , S Koscielny
- , I Carpiuc
- , C Cebotaru
- , H Vande Walle
- , M Talbot
- , P Fenaux
- & J Bosq
Leukemia 17 , 972–977

Rights & permissionsfor article Prognostic value of GST-π expression in diffuse large B-cell lymphomas . Opens in a new window.
19 July 2001
Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx
- V Ribrag
- , MEll Hajj
- , F Janot
- , T Girinsky
- , C Domenge
- , G Schwaab
- , P Fenaux
- & J Bosq
Leukemia 15 , 1123–1126

Rights & permissionsfor article Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx . Opens in a new window.
18 February 2003
Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts
- V Ribrag
- , F Suzan
- , C Ravoet
- , W Feremans
- , A Guerci
- , F Dreyfus
- , G Damaj
- , J M Vantelon
- , J H Bourhis
- & P Fenaux
Leukemia 17 , 319–322

Rights & permissionsfor article Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts . Opens in a new window.
16 April 2002
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study
- F Lefrère
- , A Delmer
- , F Suzan
- , V Levy
- , C Belanger
- , M Djabarri
- , B Arnulf
- , G Damaj
- , N Maillard
- , V Ribrag
- , M Janvier
- , C Sebban
- , R-O Casasnovas
- , R Bouabdallah
- , F Dreyfus
- , V Verkarre
- , E Delabesse
- , F Valensi
- , E McIntyre
- , N Brousse
- , B Varet
- & O Hermine
Leukemia 16 , 587–593

Rights & permissionsfor article Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study . Opens in a new window.
Research | 25 July 2011
JAK2^V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms
- M Nakatake
- , B Monte-Mor
- , N Debili
- , N Casadevall
- , V Ribrag
- , E Solary
- , W Vainchenker
- & I Plo
Oncogene 31 , 1323–1333

Rights & permissionsfor article JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms . Opens in a new window.
Research | 5 April 2013
A role for reactive oxygen species in JAK2^V617F myeloproliferative neoplasm progression
- C Marty
- , C Lacout
- , N Droin
- , J-P Le Couédic
- , V Ribrag
- , E Solary
- , W Vainchenker
- , J-L Villeval
- & I Plo
Leukemia 27 , 2187–2195

Rights & permissionsfor article A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression . Opens in a new window.

Refine your results by…

Filters

Filter By:

Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution

Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice

Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol

VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease

High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)

Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma

Prognostic value of GST-π expression in diffuse large B-cell lymphomas

Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx

Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study

JAK2^V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms

A role for reactive oxygen species in JAK2^V617F myeloproliferative neoplasm progression

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters